Withdrawal versus continuous cyclosporine therapy in kidney transplant recipients of one-haplotype-matched donors

被引：3
|
作者：
Chew-Wong, A
Alberú, J
Abasta-Jiménez, M
Alvarez-Sandoval, E
Gabilondo-Navarro, F
Correa-Rotter, R
机构：
[1] Inst Nacl Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City 14000, DF, Mexico
[2] Inst Nacl Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City 14000, DF, Mexico
[3] Inst Nacl Nutr Salvador Zubiran, Dept Transplant, Mexico City 14000, DF, Mexico
[4] Inst Nacl Nutr Salvador Zubiran, Dept Urol, Mexico City 14000, DF, Mexico
来源：
TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 1-2期
关键词：
D O I：
10.1016/S0041-1345(98)01922-8
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1106 / 1109
页数：4
相关论文
共 50 条
  • [41] Transplantation without maintenance corticosteroids in 1-haplotype and 2-haplotype HLA matched living-related renal transplant recipients treated with mycophenolate mofetil and cyclosporine
    Kupin, W
    Venkat, KK
    Goggins, M
    Douzdjian, V
    Escobar, F
    Mozes, M
    Abouljoud, M
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 744 - 745
  • [42] Twenty-year followup of kidney transplant recipients on long-term cyclosporine (CSA) therapy
    Kandaswamy, R
    Casingal, V
    Gillingham, K
    Humar, A
    Sutherland, DER
    Gruessner, RWG
    Payne, WD
    Matas, AJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 326 - 326
  • [43] TWENTY YEAR CANCER OUTCOMES OF A RANDOMIZED TRIAL OF IMMUNOSUPPRESSION IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS OF THE AUSTRALIAN MULTICENTRE TRIAL OF CYCLOSPORINE WITHDRAWAL
    Gallagher, M.
    Webster, A.
    Jardine, M.
    Perkovic, V.
    Cass, A.
    Eris, J.
    NEPHROLOGY, 2008, 13 : A119 - A119
  • [44] Chronic steroid therapy versus steroid withdrawal plus pulse steroid therapy for rejection in kidney recipients with basiliximab therapy
    Kumar, M. S. Anil
    Ranganna, K.
    Malat, G. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (08) : 1761 - 1762
  • [45] Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: A randomized, controlled study
    Abramowicz, D
    Manas, D
    Lao, M
    Vanrenterghem, Y
    del Castillo, D
    Wijngaard, P
    Fung, S
    TRANSPLANTATION, 2002, 74 (12) : 1725 - 1734
  • [46] Effect of tacrolimus versus cyclosporine on glucose metabolism of pancreas and kidney recipients in the late post-transplant period
    Havrdova, T.
    Saudek, F.
    Jedinakova, T.
    Lipar, K.
    Skibova, J.
    DIABETOLOGIA, 2011, 54 : S181 - S181
  • [47] CYCLOSPORINE VERSUS AZATHIOPRINE IN HIGH-RISK CADAVER KIDNEY-TRANSPLANT RECIPIENTS - A PROSPECTIVE RANDOMIZED STUDY
    NORMAN, DJ
    WETZSTEON, P
    BARRY, JM
    BENNETT, WM
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 1845 - 1845
  • [48] Comparative Effectiveness of Triple Immunosuppressive Therapy Versus Steroid Avoidance or Early Withdrawal Among Kidney Transplant Recipients Over Age 65.
    Harris, M.
    Irish, W.
    Pura, J.
    Barbas, A.
    Englum, B.
    Sanoff, S.
    Ellis, M.
    Vikraman, D.
    Ravindra, K.
    Kuchibhatla, M.
    Sudan, D.
    Patel, U.
    TRANSPLANTATION, 2014, 98 : 144 - 145
  • [49] Comparative Effectiveness of Triple Immunosuppressive Therapy Versus Steroid Avoidance or Early Withdrawal Among Kidney Transplant Recipients Over Age 65.
    Harris, M.
    Irish, W.
    Pura, J.
    Barbas, A.
    Englum, B.
    Sanoff, S.
    Ellis, M.
    Vikraman, D.
    Ravindra, K.
    Kuchibhatla, M.
    Sudan, D.
    Patel, U.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 144 - 145
  • [50] Induction therapy with basiliximab versus thymoglobulin in African-American kidney transplant recipients
    Haririan, A
    Morawski, K
    Sillix, DH
    El-Amm, JM
    Garnick, J
    West, MS
    Granger, DK
    Migdal, SD
    Gruber, SA
    TRANSPLANTATION, 2005, 79 (06) : 716 - 721
12345